Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
L126616-5mg | 5mg | In stock | $59.90 | |
L126616-10mg | 10mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $79.90 | |
L126616-25mg | 25mg | In stock | $159.90 | |
L126616-50mg | 50mg | In stock | $249.90 | |
L126616-100mg | 100mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $379.90 |
High affinity P-gp inhibitor
Synonyms | ZOSUQUIDAR TRIHYDROCHLORIDE [MI] | Tox21_113964 | Zosuquidar Trihydrochloride [USAN] | LY335979 trihydrochloride | LY-335979 trihydrochloride | NSC-725086 | T71107 | EX-A2191 | (R)-1-(4-((1aR,6r,10bS)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopro |
---|---|
Specifications & Purity | ≥99% |
Biochemical and Physiological Mechanisms | High affinity P-glycoprotein (P-gp) inhibitor (Kd= 79 nM). Restoresdoxorubicin sensitivity in P-gp-expressing multidrug (MDR) resistant cancer cell lines. Also potentiates antitumor efficacy oftaxol in a MDR human non-small cell lung carcinoma xenograft m |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Product Description | Zosuquidar (LY335979) is a potent modulator of P-glycoprotein-mediated multi-drug resistance with Ki of 60 nM. Phase 3. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
IUPAC Name | (2R)-1-[4-[(2R,4S)-3,3-difluoro-11-tetracyclo[10.4.0.02,4.05,10]hexadeca-1(16),5,7,9,12,14-hexaenyl]piperazin-1-yl]-3-quinolin-5-yloxypropan-2-ol;trihydrochloride |
---|---|
INCHI | InChI=1S/C32H31F2N3O2.3ClH/c33-32(34)29-22-7-1-3-9-24(22)31(25-10-4-2-8-23(25)30(29)32)37-17-15-36(16-18-37)19-21(38)20-39-28-13-5-12-27-26(28)11-6-14-35-27;;;/h1-14,21,29-31,38H,15-20H2;3*1H/t21-,29-,30+,31?;;;/m1.../s1 |
InChi Key | ZPFVQKPWGDRLHL-ZLYBXYBFSA-N |
Canonical SMILES | C1CN(CCN1CC(COC2=CC=CC3=C2C=CC=N3)O)C4C5=CC=CC=C5C6C(C6(F)F)C7=CC=CC=C47.Cl.Cl.Cl |
Isomeric SMILES | C1CN(CCN1C[C@H](COC2=CC=CC3=C2C=CC=N3)O)C4C5=CC=CC=C5[C@H]6[C@H](C6(F)F)C7=CC=CC=C47.Cl.Cl.Cl |
Alternate CAS | 167354-41-8 |
PubChem CID | 153997 |
Molecular Weight | 637 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
B23211024 | Certificate of Analysis | Nov 25, 2022 | L126616 |
B23211027 | Certificate of Analysis | Nov 25, 2022 | L126616 |
B23211125 | Certificate of Analysis | Nov 25, 2022 | L126616 |
B2321944 | Certificate of Analysis | Nov 25, 2022 | L126616 |
B2322011 | Certificate of Analysis | Nov 25, 2022 | L126616 |
H2427410 | Certificate of Analysis | Sep 15, 2021 | L126616 |
H2427412 | Certificate of Analysis | Sep 15, 2021 | L126616 |
H2427413 | Certificate of Analysis | Sep 15, 2021 | L126616 |
H2427414 | Certificate of Analysis | Sep 15, 2021 | L126616 |
H2427415 | Certificate of Analysis | Sep 15, 2021 | L126616 |
H2427416 | Certificate of Analysis | Sep 15, 2021 | L126616 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 31.85, Max Conc. mM: 50 |
---|
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P362+P364:Take off contaminated clothing and wash it before reuse. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell. |
Starting at $393.90